PLoS ONE (Jan 2023)

Gallium-68-labeled fibroblast activation protein inhibitor-46 PET in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma: A phase 2, multicenter, single arm, open label non-randomized study protocol

  • Aashna Karbhari,
  • Sherly Mosessian,
  • Kamaxi H. Trivedi,
  • Frank Valla,
  • Mark Jacobson,
  • Mark J. Truty,
  • Nandakumar G. Patnam,
  • Diane M. Simeone,
  • Elcin Zan,
  • Tracy Brennan,
  • Hongli Chen,
  • Phillip H. Kuo,
  • Ken Herrmann,
  • Ajit H. Goenka

Journal volume & issue
Vol. 18, no. 11

Abstract

Read online

No abstracts available.